Nuvalent, Inc.

NasdaqGS:NUVL Voorraadrapport

Marktkapitalisatie: US$6.9b

Nuvalent Beheer

Beheer criteriumcontroles 3/4

De CEO Nuvalent is Jim Porter, benoemd in Feb2020, heeft een ambtstermijn van 4.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 9.38M, bestaande uit 6.4% salaris en 93.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.11% van de aandelen van het bedrijf, ter waarde $ 7.29M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.5 jaar en 3.8 jaar.

Belangrijke informatie

Jim Porter

Algemeen directeur

US$9.4m

Totale compensatie

Percentage CEO-salaris6.4%
Dienstverband CEO4.8yrs
Eigendom CEO0.1%
Management gemiddelde ambtstermijn3.5yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Nov 18
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Nuvalent: Promising Data Keeps Validating Pipeline And Platform

Sep 23

Nuvalent: Likely Approvals Coming Up Do Not Justify This Valuation

Sep 17

Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business

Aug 05
Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business

Nuvalent: Making Precise Progress In Its Oncology Pipeline

Jun 24

Nuvalent: NVL-655 Could Bring Blockbuster Potential

Jun 14

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Apr 22
Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024

Feb 26

Is Nuvalent, Inc. (NASDAQ:NUVL) Trading At A 36% Discount?

Jan 07
Is Nuvalent, Inc. (NASDAQ:NUVL) Trading At A 36% Discount?

Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Sep 23
Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Jun 10
Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

We're Interested To See How Nuvalent (NASDAQ:NUVL) Uses Its Cash Hoard To Grow

Feb 24
We're Interested To See How Nuvalent (NASDAQ:NUVL) Uses Its Cash Hoard To Grow

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Sep 13
Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent GAAP EPS of -$0.38 beats by $0.03

Aug 10

Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

May 28
Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Analyse CEO-vergoeding

Hoe is Jim Porter's beloning veranderd ten opzichte van Nuvalent's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$224m

Jun 30 2024n/an/a

-US$174m

Mar 31 2024n/an/a

-US$146m

Dec 31 2023US$9mUS$603k

-US$126m

Sep 30 2023n/an/a

-US$114m

Jun 30 2023n/an/a

-US$100m

Mar 31 2023n/an/a

-US$89m

Dec 31 2022US$5mUS$580k

-US$82m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$57m

Dec 31 2021US$5mUS$424k

-US$46m

Sep 30 2021n/an/a

-US$36m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$759kUS$335k

-US$15m

Compensatie versus markt: De totale vergoeding ($USD 9.38M ) Jim } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 7.78M ).

Compensatie versus inkomsten: De vergoeding van Jim is gestegen terwijl het bedrijf verliesgevend is.

CEO

Jim Porter (48 yo)

4.8yrs

Tenure

US$9,376,872

Compensatie

Dr. James R. Porter, also known as Jim, Ph.D. has been Chief Executive Officer and President of Nuvalent, Inc. since February 1, 2020 and has been Director since February 2020. He joined Nuvalent during co...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
James Porter
CEO, President & Director4.8yrsUS$9.38m0.11%
$ 7.3m
Matthew Shair
Founder7.8yrsUS$688.18k2.32%
$ 159.6m
Alexandra Balcom
CFO & Treasurer3.8yrsUS$3.54m0.047%
$ 3.2m
Christopher Turner
Chief Medical Officer3.7yrsUS$3.60m0.020%
$ 1.4m
Benjamin Lane
Senior Vice President of Technical Operations2.3yrsgeen gegevensgeen gegevens
Henry Pelish
Chief Scientific Officerless than a yeargeen gegevensgeen gegevens
Deborah Miller
Chief Legal Officer & Secretary3.4yrsUS$1.69m0.047%
$ 3.2m
Matthew Metivier
Senior Vice President of Human Resources2.7yrsgeen gegevensgeen gegevens
Darlene Noci
Chief Development Officer3.8yrsgeen gegevens0.047%
$ 3.2m
John Soglia
Senior Vice President of Translational Development1.8yrsgeen gegevensgeen gegevens

3.5yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van NUVL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
James Porter
CEO, President & Director4.8yrsUS$9.38m0.11%
$ 7.3m
Matthew Shair
Founder7.8yrsUS$688.18k2.32%
$ 159.6m
Sapna Srivastava
Independent Non-Executive Director3.3yrsUS$503.18k0%
$ 0
Anna Protopapas
Independent Chairman2.7yrsUS$523.18k0%
$ 0
Pasi Antero Janne
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
D. Gilliland
Independent Non-Executive Director3.8yrsUS$495.68k0%
$ 0
Michael Meyers
Member of Scientific Advisory Board & Independent Director2.1yrsUS$494.36k0%
$ 0
Cameron Wheeler
Independent Non-Executive Director7.8yrsUS$499.45kgeen gegevens
Joseph Pearlberg
Independent Non-Executive Director3.8yrsUS$494.00kgeen gegevens
Emily Conley
Independent Director2.8yrsUS$495.90k0.000010%
$ 687.5
D. Camidge
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Aaron Hata
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens

3.8yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van NUVL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).